The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemotherapy (CT) for isolated locoregional recurrence (ILRR) of breast cancer in ER-positive (ER+) and ER-negative (ER-) cohorts: Final analysis of the CALOR trial.
 
Irene Wapnir
Research Funding - Novadaq Technologies; OncoSec
 
Karen N. Price
No Relationships to Disclose
 
Stewart J. Anderson
No Relationships to Disclose
 
Andre Robidoux
No Relationships to Disclose
 
Miguel Martin
Consulting or Advisory Role - Amgen; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst)
 
J. W.R. Nortier
No Relationships to Disclose
 
Alexander H. G. Paterson
No Relationships to Disclose
 
Mothaffar F. Rimawi
Consulting or Advisory Role - Celgene
 
Istvan Lang
No Relationships to Disclose
 
José Manuel Baena Cañada
No Relationships to Disclose
 
Beat J. K. Thurlimann
Stock and Other Ownership Interests - Novartis; Novartis (I); Roche; Roche (I)
Honoraria - Roche
Travel, Accommodations, Expenses - Pierre Fabre; Roche
 
Eleftherios P. Mamounas
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - bioTheranostics; Celcuity; Celgene; Genomic Health; GRAIL; Macrogenics; Novartis; Pfizer; Ventana Medical Systems
Speakers' Bureau - Genentech/Roche; Genomic Health
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Genomic Health
 
Charles E. Geyer
Consulting or Advisory Role - Myriad Genetics; Stemnion
Research Funding - Incyte; Merck
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Genentech/Roche
 
Shari I. Gelber
No Relationships to Disclose
 
Alan S. Coates
No Relationships to Disclose
 
Richard D. Gelber
Research Funding - AstraZeneca (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Priya Rastogi
No Relationships to Disclose
 
Meredith M. Regan
Consulting or Advisory Role - Ipsen (Inst); Merck
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); OncoGenex (Inst); Pfizer (Inst); Pierre Fabre (Inst); Veridex (Inst)
 
Norman Wolmark
Research Funding - AbbVie (Inst); AbbVie (Inst); Bayer (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - AbbVie (Inst)
Travel, Accommodations, Expenses - AbbVie; Abbvie; Genentech; GHI Pharma; Sanofi
 
Stefan Paul Aebi
Consulting or Advisory Role - AstraZeneca (Inst); Roche (Inst)